泽璟制药-U
(688266)
| 流通市值：221.24亿 | | | 总市值：221.24亿 |
| 流通股本：2.65亿 | | | 总股本：2.65亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,584,156,060.21 | 2,094,134,742.25 | 2,218,105,122.56 | 2,031,180,276.61 |
| 交易性金融资产 | 626,140,930.69 | 375,575,616.1 | 465,530,630.04 | - |
| 应收票据及应收账款 | 223,562,756.86 | 204,288,205.63 | 187,928,977.51 | 154,252,012.65 |
| 其中：应收票据 | 82,291.26 | 6,937.8 | 2,996,390.25 | 3,029,214.25 |
| 应收账款 | 223,480,465.6 | 204,281,267.83 | 184,932,587.26 | 151,222,798.4 |
| 预付款项 | 65,807,115.26 | 63,881,678.24 | 68,169,270.6 | 44,992,292.23 |
| 其他应收款合计 | 7,257,930 | 7,577,623.26 | 10,532,125.81 | 10,271,230.89 |
| 存货 | 196,681,658.96 | 192,872,530.72 | 178,263,420.26 | 173,267,046.83 |
| 合同资产 | - | - | 2,648,010.82 | - |
| 其他流动资产 | 30,420,882.21 | 23,638,383.56 | 27,738,930.67 | 29,141,302.69 |
| 流动资产合计 | 2,734,027,334.19 | 2,961,968,779.76 | 3,158,916,488.27 | 2,443,104,161.9 |
| 非流动资产: | | | | |
| 固定资产 | 439,906,020.37 | 444,207,534.88 | 196,583,139.18 | 192,580,288.82 |
| 在建工程 | 11,519,524.24 | 64,900,885.06 | 283,160,268.01 | 275,930,391.26 |
| 使用权资产 | 12,680,181.58 | 13,508,854.95 | 15,455,643.77 | 17,375,222.18 |
| 无形资产 | 24,174,945.22 | 24,457,846.91 | 26,921,771.76 | 30,588,770.02 |
| 长期待摊费用 | 65,014,603.13 | 3,879,317.29 | 4,899,798.46 | 5,980,261.8 |
| 其他非流动资产 | 20,083,206.38 | 13,316,930.4 | 2,449,037.42 | 3,626,494.92 |
| 非流动资产合计 | 573,378,480.92 | 564,271,369.49 | 529,469,658.6 | 526,081,429 |
| 资产总计 | 3,307,405,815.11 | 3,526,240,149.25 | 3,688,386,146.87 | 2,969,185,590.9 |
| 流动负债: | | | | |
| 短期借款 | 548,332,185.71 | 674,863,607.69 | 842,994,687.63 | 989,050,579.42 |
| 应付票据及应付账款 | 264,266,887.66 | 293,741,023.99 | 265,097,688.67 | 244,162,944.44 |
| 其中：应付票据 | 32,364,856.41 | 39,224,420.94 | 50,959,797.52 | 22,468,876.58 |
| 应付账款 | 231,902,031.25 | 254,516,603.05 | 214,137,891.15 | 221,694,067.86 |
| 预收款项 | 15,290.52 | 38,226.3 | 61,162.08 | 84,097.86 |
| 合同负债 | 94,670,988.08 | 39,292,765.11 | 46,787,378.38 | 1,247,644.85 |
| 应付职工薪酬 | 88,148,957.07 | 74,096,082.25 | 55,764,589.78 | 77,148,573.05 |
| 应交税费 | 31,386,701.84 | 24,930,993.4 | 37,430,099.91 | 23,417,972.21 |
| 其他应付款合计 | 29,979,850.6 | 29,124,419.06 | 38,588,640 | 41,395,967.61 |
| 一年内到期的非流动负债 | 2,645,759.04 | 48,857,669.41 | 51,107,284.82 | 51,107,284.82 |
| 其他流动负债 | 820,945.59 | 220,096.74 | 689,953.64 | 324,810.06 |
| 流动负债合计 | 1,060,267,566.11 | 1,185,164,883.95 | 1,338,521,484.91 | 1,427,939,874.32 |
| 非流动负债: | | | | |
| 长期借款 | - | 83,500,000 | 83,999,999.96 | 83,999,999.96 |
| 租赁负债 | 8,872,985.93 | 5,716,122.71 | 7,512,212.61 | 8,597,765.62 |
| 递延收益 | 8,714,000 | 7,683,000 | 8,069,500 | 8,069,500 |
| 递延所得税负债 | - | - | 645,655.51 | 1,639,657.87 |
| 其他非流动负债 | 510,796,646.88 | 523,689,728.61 | 536,582,810.34 | 358,490,567.13 |
| 非流动负债合计 | 528,383,632.81 | 620,588,851.32 | 636,810,178.42 | 460,797,490.58 |
| 负债合计 | 1,588,651,198.92 | 1,805,753,735.27 | 1,975,331,663.33 | 1,888,737,364.9 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 264,708,186 | 264,708,186 | 264,708,186 | 264,708,186 |
| 资本公积 | 3,109,476,536.44 | 3,109,476,536.44 | 3,109,476,536.44 | 3,109,476,536.44 |
| 其他综合收益 | -14,008,043.2 | -14,020,760.95 | -14,054,159.76 | -14,047,844.8 |
| 未分配利润 | -1,641,422,063.05 | -1,639,677,547.51 | -1,647,076,079.14 | -2,279,688,651.64 |
| 归属于母公司股东权益合计 | 1,718,754,616.19 | 1,720,486,413.98 | 1,713,054,483.54 | 1,080,448,226 |
| 股东权益合计 | 1,718,754,616.19 | 1,720,486,413.98 | 1,713,054,483.54 | 1,080,448,226 |
| 负债和股东权益合计 | 3,307,405,815.11 | 3,526,240,149.25 | 3,688,386,146.87 | 2,969,185,590.9 |
| 公告日期 | 2026-10-31 | 2026-08-01 | 2026-04-29 | 2026-03-28 |
| 审计意见(境内) | | | | 标准无保留意见 |